Results 281 to 290 of about 994,709 (302)
Some of the next articles are maybe not open access.
Clinical Journal of Oncology Nursing, 2023
BACKGROUND Bone metastases are the most common site of metastatic disease in breast cancer and can result in significant pain and an increased risk of skeletal-related events (SREs). Uncontrolled pain can further lead to negative outcomes.
K. Hamash, Suzanne L Walker
semanticscholar +1 more source
BACKGROUND Bone metastases are the most common site of metastatic disease in breast cancer and can result in significant pain and an increased risk of skeletal-related events (SREs). Uncontrolled pain can further lead to negative outcomes.
K. Hamash, Suzanne L Walker
semanticscholar +1 more source
ACS Nano, 2022
Bone metastasis is a common metastasis site such as lung cancer, prostate cancer, and other malignant tumors. The occurrence of bone metastases of lung cancer is often accompanied by bone loss, fracture, and other skeletal-related events (SREs) caused by
Yimin Niu +9 more
semanticscholar +1 more source
Bone metastasis is a common metastasis site such as lung cancer, prostate cancer, and other malignant tumors. The occurrence of bone metastases of lung cancer is often accompanied by bone loss, fracture, and other skeletal-related events (SREs) caused by
Yimin Niu +9 more
semanticscholar +1 more source
Expert Opinion on Biological Therapy, 2020
Introduction Repurposing denosumab in lung cancer therapeutics capitalizes on its well-established role in preventing the skeletal related events (SREs) and its emerging, yet elusive, bone-independent role, assigned to inhibit the contribution of RANKL ...
M. Deligiorgi, D. Trafalis
semanticscholar +1 more source
Introduction Repurposing denosumab in lung cancer therapeutics capitalizes on its well-established role in preventing the skeletal related events (SREs) and its emerging, yet elusive, bone-independent role, assigned to inhibit the contribution of RANKL ...
M. Deligiorgi, D. Trafalis
semanticscholar +1 more source
Journal of Surgical Oncology
Metastatic bone disease is estimated to develop in up to 17% of patients with melanoma, compromising skeleton integrity resulting in skeletal‐related events (SREs), which impair quality of life and reduce survival.
Michelle R. Shimizu +10 more
semanticscholar +1 more source
Metastatic bone disease is estimated to develop in up to 17% of patients with melanoma, compromising skeleton integrity resulting in skeletal‐related events (SREs), which impair quality of life and reduce survival.
Michelle R. Shimizu +10 more
semanticscholar +1 more source
Predicting Skeletal-related Events Using SINS
SpineStudy Design. Predictive study utilized retrospectively collected data. Objective. The primary objective was to evaluate the predictive association between the Spine Instability Neoplastic Score (SINS) and Skeletal-related events (SREs).
Kazuo Nakanishi +6 more
semanticscholar +1 more source
Future Oncology, 2019
AIM Estimate the incidence of bone metastases (BM) and skeletal-related events according to the histological subtype of lung cancer and its impact on patient survival.
G. T. Silva +3 more
semanticscholar +1 more source
AIM Estimate the incidence of bone metastases (BM) and skeletal-related events according to the histological subtype of lung cancer and its impact on patient survival.
G. T. Silva +3 more
semanticscholar +1 more source
Current Medical Research and Opinion, 2018
Objectives: Skeletal-related events (SREs), i.e. pathologic fractures, spinal cord compression, surgery and radiation to bone, are serious skeletal complications that occur frequently in patients with bone metastases (BMs) from solid tumors (STs ...
D. Bhowmik +4 more
semanticscholar +1 more source
Objectives: Skeletal-related events (SREs), i.e. pathologic fractures, spinal cord compression, surgery and radiation to bone, are serious skeletal complications that occur frequently in patients with bone metastases (BMs) from solid tumors (STs ...
D. Bhowmik +4 more
semanticscholar +1 more source
European Review for Medical and Pharmacological Sciences, 2022
R. Berardi +3 more
semanticscholar +1 more source
R. Berardi +3 more
semanticscholar +1 more source
Breast Cancer Research and Treatment, 2020
H. Miyashita, Christina Cruz, S. Malamud
semanticscholar +1 more source
H. Miyashita, Christina Cruz, S. Malamud
semanticscholar +1 more source

